Who has invested in SeLux Diagnostics?

RA Capital Management are named among the investors backing SeLux Diagnostics.

SeLux Diagnostics Funding: $78M Raised, Series B (2024)

SeLux Diagnostics funding overview

SeLux Diagnostics is based in Boston. SeLux Diagnostics has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in April 2024. The round record for SeLux Diagnostics runs through 2024; nothing later has been disclosed. Investors on record include RA Capital Management.

SeLux Diagnostics at a glance

Total raised: $78M
Latest round: Series B
Latest round date: April 2024
Headquarters: Boston
Notable investors: RA Capital Management

Frequently asked about SeLux Diagnostics funding

How much has SeLux Diagnostics raised?: SeLux Diagnostics has raised $78M in total disclosed funding across the rounds on record.
Who has invested in SeLux Diagnostics?: RA Capital Management are named among the investors backing SeLux Diagnostics.
What was the latest SeLux Diagnostics funding round?: The most recent disclosed round is a Series B, announced in April 2024.
Where is SeLux Diagnostics based?: SeLux Diagnostics is based in Boston.
When did SeLux Diagnostics last raise?: The last disclosed SeLux Diagnostics round closed in April 2024 at Series B.

SeLux Diagnostics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.

SeLux Diagnostics Funding: $78M Raised, Series B (2024)

SeLux Diagnostics funding overview

SeLux Diagnostics at a glance

Frequently asked about SeLux Diagnostics funding

Companies related to SeLux Diagnostics (36)

Browse related funding lists (6)